Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Biomerica Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +9 vs. Q1 2026
- Shares held
- 125.2K
- +13.5K (+12.1%) vs. Q1 2026
- Total value
- $220.0K
- −$16.1K (−6.8%) vs. Q1 2026
- New holders
- 9
- 1 more added
- Sold out
- 0
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 2 | $4 | 0.00% | +2 | New |
| Federation des caisses Desjardins du Quebec | 3 | $5 | 0.00% | +3 | New |
| MCF Advisors LLC | 6 | $11 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6 | $11 | 0.00% | +6 | New |
| Larson Financial Group LLC | 12 | $21 | 0.00% | +12 | New |
| IFG Advisory, LLC | 25 | $44 | 0.00% | +25 | New |
| FMR LLC | 83 | $146 | 0.00% | +83 | New |
| Harbour Investments, Inc. | 125 | $220 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 200 | $352 | 0.00% | −625−75.8% | Reduced |
| Tower Research Capital LLC (TRC) | 238 | $419 | 0.00% | +238 | New |
| GWM Advisors LLC | 3,603 | $6.34K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 6,613 | $11.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,951 | $12.2K | 0.00% | +6,432+1,239.3% | Added |
| LPL Financial LLC | 10,849 | $19.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,640 | $22.2K | 0.00% | +12,640 | New |
| Vanguard Capital Management LLC | 14,514 | $25.5K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 18,636 | $32.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 24,347 | $42.9K | 0.00% | −31,695−56.6% | Reduced |
| HRT Financial LP | 26,374 | $46.0K | 0.00% | +26,374 | New |